TMPRSS2 and neoplasm: TMPRSS2-ERG fusions are responsible for checkpoint impairment in the cell cycle and for tumor proliferation, but also tumor cell migration and invasiveness by overexpression on metalloproteinase 9 (MMP9) and plexin A2.